We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The highly politicized debate over whether hydroxychloroquine is or is not useful to COVID-19 patients appears to be far from over. A coalition of more than 180 doctors and researchers have signed an open letter questioning the findings of a study showing that hydroxychloroquine and chloroquine have no benefit in treating COVID-19 patients. Read More
President Trump announced Friday that the U.S. will sever its financial ties to the World Health Organization (WHO), claiming the organization failed to implement requested reforms and was receiving an unfair proportion of its funding from the U.S. Read More
PureTech Health said it will begin human trials on an experimental treatment for respiratory complications following recovery from COVID-19 infections. Read More
Novartis-subsidiary AveXis has entered into an agreement to manufacture a COVID-19 vaccine being developed by Massachusetts General Hospital and Massachusetts Eye and Ear. Read More
Top pharmaceutical executives pushed back yesterday against the World Health Organization’s plan for sharing patent rights and product data for COVID-19 countermeasures. Read More
GlaxoSmithKline (GSK) said it plans to manufacture 1 billion doses of its vaccine adjuvant next year to support multiple COVID-19 vaccine candidates. Read More
Roche has begun a phase 3 trial of its rheumatoid arthritis treatment Actemra (tocilizumab) with Gilead Sciences’ remdesivir for treatment of patients with severe COVID-19 pneumonia. Read More
The agreement will begin immediately to address Moderna's increasing demand over the upcoming months and will focus on securing future long-term supply. Read More
The agreement builds upon a previous deal that AstraZeneca and the University of Oxford entered into last month, under which the company is responsible for manufacturing the vaccine. Read More